MSD Brenzys Pharmacy Program

In April 2018, Kos designed, developed, and implemented the MSD Brenzys® Pharmacy Program which provides support to patients who have been dispensed Brenzys® (etanercept). Participating patients are eligible to be enrolled in the MSD Harmony™. It is a biosimilar to the reference biological medicine Enbrel© (etanercept).